BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15366876)

  • 1. Pose scoring by NMR.
    Wang B; Raha K; Merz KM
    J Am Chem Soc; 2004 Sep; 126(37):11430-1. PubMed ID: 15366876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the binding site structure of the cellular retinol-binding protein (CRBP) by ligand NMR chemical shift perturbations.
    Wang B; Merz KM
    J Am Chem Soc; 2005 Apr; 127(15):5310-1. PubMed ID: 15826155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-ligand NOE matching: a high-throughput method for binding pose evaluation that does not require protein NMR resonance assignments.
    Constantine KL; Davis ME; Metzler WJ; Mueller L; Claus BL
    J Am Chem Soc; 2006 Jun; 128(22):7252-63. PubMed ID: 16734479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
    Brath U; Akke M
    J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein-ligand interactions by high-resolution solid-state NMR spectroscopy.
    Zech SG; Olejniczak E; Hajduk P; Mack J; McDermott AE
    J Am Chem Soc; 2004 Nov; 126(43):13948-53. PubMed ID: 15506755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule binding sites on proteins established by paramagnetic NMR spectroscopy.
    Guan JY; Keizers PH; Liu WM; Löhr F; Skinner SP; Heeneman EA; Schwalbe H; Ubbink M; Siegal G
    J Am Chem Soc; 2013 Apr; 135(15):5859-68. PubMed ID: 23509882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steering protein-ligand docking with quantitative NMR chemical shift perturbations.
    González-Ruiz D; Gohlke H
    J Chem Inf Model; 2009 Oct; 49(10):2260-71. PubMed ID: 19795907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How much NMR data is required to determine a protein-ligand complex structure?
    Schieborr U; Vogtherr M; Elshorst B; Betz M; Grimme S; Pescatore B; Langer T; Saxena K; Schwalbe H
    Chembiochem; 2005 Oct; 6(10):1891-8. PubMed ID: 16013076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship by NMR and by computer: a comparative study.
    Sirockin F; Sich C; Improta S; Schaefer M; Saudek V; Froloff N; Karplus M; Dejaegere A
    J Am Chem Soc; 2002 Sep; 124(37):11073-84. PubMed ID: 12224955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-cell solid-state NMR as a tool to study proteins in large complexes.
    Reckel S; Lopez JJ; Löhr F; Glaubitz C; Dötsch V
    Chembiochem; 2012 Mar; 13(4):534-7. PubMed ID: 22298299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.
    Stebbins JL; Zhang Z; Chen J; Wu B; Emdadi A; Williams ME; Cashman J; Pellecchia M
    J Med Chem; 2007 Dec; 50(26):6607-17. PubMed ID: 18038971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of protein/ligand interactions with NMR diffusion measurements: the importance of eliminating the protein background.
    Derrick TS; McCord EF; Larive CK
    J Magn Reson; 2002 Apr; 155(2):217-25. PubMed ID: 12036332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folding of small proteins by Monte Carlo simulations with chemical shift restraints without the use of molecular fragment replacement or structural homology.
    Robustelli P; Cavalli A; Dobson CM; Vendruscolo M; Salvatella X
    J Phys Chem B; 2009 Jun; 113(22):7890-6. PubMed ID: 19425536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in drug 13C NMR chemical shifts as a tool for monitoring interactions with DNA.
    Boudreau EA; Pelczer I; Borer PN; Heffron GJ; LaPlante SR
    Biophys Chem; 2004 Jun; 109(3):333-44. PubMed ID: 15110931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
    Bizzarri M; Marsili S; Procacci P
    J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations.
    Solomentsev G; Diehl C; Akke M
    Biochemistry; 2018 Mar; 57(9):1451-1461. PubMed ID: 29412644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dynamics of human FKBP12 revealed by methyl 13C rotating frame relaxation dispersion NMR spectroscopy.
    Brath U; Akke M; Yang D; Kay LE; Mulder FA
    J Am Chem Soc; 2006 May; 128(17):5718-27. PubMed ID: 16637639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-ligand interactions: identification and characterization of ligand binding by NMR spectroscopy.
    Benie AJ; Moser R; Bäuml E; Blaas D; Peters T
    J Am Chem Soc; 2003 Jan; 125(1):14-5. PubMed ID: 12515488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors.
    Meyer B; Peters T
    Angew Chem Int Ed Engl; 2003 Feb; 42(8):864-90. PubMed ID: 12596167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.